T1	Participants 98 114	cancer patients.
T2	Participants 374 429	cancer patients with dysfunctional fear of progression.
T3	Participants 539 590	cancer patients receiving inpatient rehabilitation.
T4	Participants 749 814	A total of 174 patients were included in the economic evaluation.
T5	Participants 1542 1586	cancer patients with high levels of anxiety.
